First, SGKL treatment decreased the CRS‐increased immobile time and elevated the CRS‐repressed alterations of body weight, sugar preference, and rearing/crossing counts in the open‐field experiment, which revealed a significant role of SGKL treatment in depression‐like behaviors. Here, SGK3 is linked to depressive symptom measurement.